帕克利塔塞尔诱导的不良反应:多器官毒性和分子机制的洞察
Antoinette G Naeem1, Sylvia F Fawzi2, Radwa M Elmorsi3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.
Naunyn-Schmiedeberg's archives of pharmacology
|August 27, 2025
概括
帕克利塔塞尔 (PTX) 是固体瘤的重要化疗药物,但其非向性导致显著的毒性. 本综述详细介绍了PTX诱导的副作用背后的病理机制.
科学领域:
- 癌症学
- 药理学
- 毒理学
背景情况:
- 帕克利塔塞尔 (PTX) 是一种广泛使用的对各种固体瘤有效的化学疗法剂.
- 它的抗癌效果源于诸如线粒体停止,线粒体损伤和亡诱导等机制.
- 然而,PTX是一种非向药物,导致剂量限制的毒性影响患者的生活质量.
研究的目的:
- 审查和阐明与帕克利塔塞尔 (PTX) 相关的常见临床毒性背后的病理机制.
- 提供PTX诱导的副作用的全面概述,包括认知障碍,外围神经病变和器官特异性毒性.
主要方法:
- 对帕克利塔克塞尔 (PTX) 机制和毒性现有研究的文献综述.
- 涉及PTX诱导的不良事件的病理途径的合成.
- 根据受影响的系统对毒性的分类.
主要成果:
- 确定的常见PTX毒性:认知障碍,外围神经病变,丸,肺,心脏,肝脏和脏毒性.
- 强调许多PTX毒性的确切病理机制仍然不完全理解.
- 提出了每种审查的毒性病理机制的详细建议.
结论:
- 了解PTX毒性的机制对于减轻副作用和改善患者的结果至关重要.
- 需要对PTX诱导的病理途径进行进一步的研究.
- 这一审查巩固了目前关于PTX毒性的知识,有助于临床管理和未来的治疗策略.
相关概念视频
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


